DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Frías JP, Guja C, Hardy E. et al.
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomized controlled trial.
Lancet Diabetes Endocrinol 2016;
4: 1004-1016
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.